CRSP CLUSTER SEC Filing Analysis

Final — all horizons settled through T+60d

CRSP ▲ +6.57% at T+60d

NEUTRAL call ✓ call won +6.57% · α vs SPY -3.92% · entry $48.42 → $51.60

Last close $51.60 (close Jun 8) · +6.57% from $48.42 entry

Entry anchored
Mar 13, 03:59 PM ET
via Databento tick

T+1d

+3.45%

call +3.45% · α +3.18%

$50.09

settled 3mo ago

T+5d

-3.18%

call -3.18% · α -1.14%

$46.88

settled 3mo ago

T+20d

+17.43%

call +17.43% · α +13.65%

$56.86

settled 8w ago

T+60d

+6.57%

call +6.57% · α -3.92%

$51.60

settled 19h ago

Price Chart

Loading chart...

Executive Summary

CRISPR Therapeutics CFO Prasad Raju sold $173,460 worth of shares in an open-market transaction, while both the CFO and Chief Medical Officer received non-cash equity awards totaling 140,748 shares. The only material transaction was the CFO's sale, which represents a small fraction of the company's $4.5B market cap.

Key Financial Metrics

Direction

selling

Total Value

$173.5K

Insiders

2

Actionable Insight

The CFO's sale is routine and not materially concerning given its small size relative to market cap. Non-cash grants are standard compensation and should not be interpreted as trading signals. Monitor for additional selling or news ahead of next earnings.

Key Facts

CFO Prasad Raju sold 3,708 shares for $173,460 in an open-market transaction on March 23, 2026.
On March 20, 2026, CFO Raju received 65,999 shares and exercised 12,500 shares via derivatives, all non-cash events.
Chief Medical Officer Naimish Patel received 68,499 shares in non-cash grants on March 20, 2026.
Total open-market selling in the cluster: $173,460 (0.0038% of $4.5B market cap).
No open-market purchases were made by insiders in this cluster.

Financial Impact

$173,460 in open-market sales by CFO, representing 0.0038% of market cap

insider sentimentshare count

Risk Factors

CFO selling while holding newly granted shares could signal lack of conviction, though the amount is small.
No insider buying to offset the sale, reducing potential bullish signal.

Market Snapshot

Exchange

Nasdaq

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

Document	Accession Number
CONTEXT: Insider Cluster Data (7 trades, 7d window)	cluster-CRSP-1774388233457

4 reports for CRSP

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for CRSP — sortable, filterable
	Type				Now
Jun 4, 2026 5d ago	8-K NEUTRAL ★ 3/10	$56.90 awaiting T+20	awaiting T+20	—	$51.60 (−9.31%)
May 4, 2026 5w ago	8-K BEARISH ★ 5/10	$52.38 $52.02	▲ +0.69%	▲ +5.64%	$51.60 (+1.49%)
Apr 21, 2026 7w ago	DEFA14A NEUTRAL ★ 3/10	$55.54 $48.56	▼ −12.57%	▼ −17.48%	$51.60 (−7.09%)
Mar 16, 2026 12w ago	Insider Cluster NEUTRAL ★ 3/10	$48.42 $56.86	▲ +17.43%	▲ +13.65%	$51.60 (+6.57%)

US Market Status

Market Closed — Opens in 6h 55m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access